NEWS UPDATE
Date: 2 November 2021
Date: 2 November 2021
SFLG remembers its generous legatees on All Souls Day
Garden of Remembrance launched in memoriam
Garden of Remembrance launched in memoriam
London, UK, All Soul Day: St Francis Leprosy Guild remembers with grateful thanks, all its legators, whose generosity means that a leprosy-free world is becoming ever nearer.
At the recent Mass celebrating SFLG’s 125th Anniversary, held at St George’s Cathedral, Southwark, the names of all deceased donors were remembered by Chief Concelebrant, Archbishop John Wilson. He said:
whenever you leave a gift to St Francis Leprosy Guild, you will be forever in our prayers. In loving memory, I bless this Book of Remembrance."
A Garden of Remembrance was formally launched, online, to record the names of those who have recently passed away leaving legacies to SFLG in their wills. SFLG's Chief Executive Officer, Clare McIntosh said:
You cannot overestimate the importance of legacies on the successful operation of our ministry.” She continued, “any gift that you leave in your will to SFLG, will make a big difference to people affected by leprosy. Your legacy will prevent life-changing disabilities from developing and restore hope and dignity to some of the poorest, most marginalised people in the world." She concluded: "when leprosy is defeated once and for all, you will know that you played your part.”
SFLG has partnered with the National Free Wills Network, which means that SFLG’s supporters may have a will written or updated for free by a local, qualified solicitor. For more information, please click on this link .
All Souls Day, also known as the Commemoration of All the Faithful Departed and the Day of the Dead, is a day of prayer and remembrance for the souls of those who have died and is observed by Catholics and other Christian denominations on 2 November every year. All Saints Day is celebrated on 1 November 2021.
For more information please contact:
Clare McIntosh
Chief Executive Officer
St Francis Leprosy Guild
London W10 6EJ
Tel: +44 (0)7754 592240
Email: enquiries@stfrancisleprosy.org
Twitter @StLeprosy
Facebook
Clare McIntosh
Chief Executive Officer
St Francis Leprosy Guild
London W10 6EJ
Tel: +44 (0)7754 592240
Email: enquiries@stfrancisleprosy.org
Twitter @StLeprosy
About St Francis Leprosy Guild (SFLG)
SFLG is a UK-based, Catholic charity that is working towards a -leprosy-free world. We support the work of over 40 leprosy centres, clinics, hospitals, care homes and leprosy-related projects. We work in 15 countries worldwide in Africa, Asia and South America where leprosy is endemic.
About leprosy
1. What is leprosy?
Leprosy (also known as Hansen’s disease) is a complex, chronic neglected tropical disease caused by the Mycobacterium leprae bacterium. It affects the skin, the upper respiratory tract and peripheral nerves in the hands and feet, and the eyes. Leprosy can affect anyone, at any age, but it is linked to poverty, malnutrition, and genetic susceptibility.
Leprosy remains an important health problem in low and middle-income countries worldwide.
2. How is leprosy transmitted?
It is thought that leprosy is transmitted via droplets from the nose combined with prolonged, close contact with infected individuals.
3. How is leprosy diagnosed?
Leprosy is difficult to diagnose at its early stages, but it often presents as numb patches on the skin. Currently, the most reliable method to diagnose leprosy, is a slit-skin-smear test in the laboratory.
Leprosy may incubate for up to twenty years before presenting with any signs. If leprosy remains undiagnosed like this, the person affected may unwillingly transmit the disease throughout a community. However, within a short period of receiving multidrug therapy, a person affected by leprosy will no longer be infectious. If leprosy is diagnosed in its early stages, it can be treated readily, and it will not cause disabilities. Preventing disabilities from developing means people with leprosy are less likely to suffer from the stigma and discrimination that can destroy their livelihoods and entire lives.
4. How infectious is leprosy?
95% of most populations have a natural immunity to leprosy. The remaining 5% become vulnerable, mainly through poor nutrition, poor living conditions, lack of hygiene and a weakened immune system. Leprosy is not hereditary.
5. Why are people with leprosy often so disfigured?
People with leprosy lose all feeling in the affected areas and as a result, there is diminished awareness of harm from trauma or heat. Without treatment, the lack of sensation can lead to permanent damage to skin, nerves, limbs, and eyes. It can also lead to the development of reoccurring, lifelong, hard-to- treat ulcers.
6. Is there a cure? How is leprosy treated?
Leprosy can be cured using multidrug therapy (MDT), available at no cost to patients from the World Health Organization. If MDT is taken in the early stages of the disease, permanent damage to nerves is completely avoided.
7. How many are affected by leprosy in the world today?
The latest *WHO statistics reveal that in 2020 there were over 127,000 new cases of leprosy diagnosed. Of concern and indicating ongoing transmission, the number of children newly detected was nearly 8,629.
These statistics do not account for those people who have leprosy with no symptoms or, who are not diagnosed and are unwittingly transmitting it to their communities. In addition, the statistics do not include those individuals who have been treated for leprosy, but whose disabilities, caused by leprosy need ongoing healthcare needs, or those who are subject to leprosy stigma and discrimination.
8. Which countries have leprosy, where is leprosy endemic?
*The WHO has identified 23 global priority countries for leprosy, where 95.9% of the global total of people detected with leprosy are found. The 23 countries are: Angola, Bangladesh, Brazil, Comoros, Cote Ivoire, DR Congo, Egypt, Ethiopia, India, Indonesia, Kiribati, Madagascar, Micronesia, Mozambique, Myanmar, Nepal, Nigeria, Philippines, South Sudan, Sri Lanka, Sudan, Somalia and Tanzania.
The highest number of people newly detected with leprosy in 2020 live in India with 65,147, followed by Brazil with 17,979 and Indonesia with 11,173.
*WHO Weekly epidemiological record, Global Leprosy Update 10 September 2020, 36, 2021, 96, 421-444
SFLG is a UK-based, Catholic charity that is working towards a -leprosy-free world. We support the work of over 40 leprosy centres, clinics, hospitals, care homes and leprosy-related projects. We work in 15 countries worldwide in Africa, Asia and South America where leprosy is endemic.
About leprosy
1. What is leprosy?
Leprosy (also known as Hansen’s disease) is a complex, chronic neglected tropical disease caused by the Mycobacterium leprae bacterium. It affects the skin, the upper respiratory tract and peripheral nerves in the hands and feet, and the eyes. Leprosy can affect anyone, at any age, but it is linked to poverty, malnutrition, and genetic susceptibility.
Leprosy remains an important health problem in low and middle-income countries worldwide.
2. How is leprosy transmitted?
It is thought that leprosy is transmitted via droplets from the nose combined with prolonged, close contact with infected individuals.
3. How is leprosy diagnosed?
Leprosy is difficult to diagnose at its early stages, but it often presents as numb patches on the skin. Currently, the most reliable method to diagnose leprosy, is a slit-skin-smear test in the laboratory.
Leprosy may incubate for up to twenty years before presenting with any signs. If leprosy remains undiagnosed like this, the person affected may unwillingly transmit the disease throughout a community. However, within a short period of receiving multidrug therapy, a person affected by leprosy will no longer be infectious. If leprosy is diagnosed in its early stages, it can be treated readily, and it will not cause disabilities. Preventing disabilities from developing means people with leprosy are less likely to suffer from the stigma and discrimination that can destroy their livelihoods and entire lives.
4. How infectious is leprosy?
95% of most populations have a natural immunity to leprosy. The remaining 5% become vulnerable, mainly through poor nutrition, poor living conditions, lack of hygiene and a weakened immune system. Leprosy is not hereditary.
5. Why are people with leprosy often so disfigured?
People with leprosy lose all feeling in the affected areas and as a result, there is diminished awareness of harm from trauma or heat. Without treatment, the lack of sensation can lead to permanent damage to skin, nerves, limbs, and eyes. It can also lead to the development of reoccurring, lifelong, hard-to- treat ulcers.
6. Is there a cure? How is leprosy treated?
Leprosy can be cured using multidrug therapy (MDT), available at no cost to patients from the World Health Organization. If MDT is taken in the early stages of the disease, permanent damage to nerves is completely avoided.
7. How many are affected by leprosy in the world today?
The latest *WHO statistics reveal that in 2020 there were over 127,000 new cases of leprosy diagnosed. Of concern and indicating ongoing transmission, the number of children newly detected was nearly 8,629.
These statistics do not account for those people who have leprosy with no symptoms or, who are not diagnosed and are unwittingly transmitting it to their communities. In addition, the statistics do not include those individuals who have been treated for leprosy, but whose disabilities, caused by leprosy need ongoing healthcare needs, or those who are subject to leprosy stigma and discrimination.
8. Which countries have leprosy, where is leprosy endemic?
*The WHO has identified 23 global priority countries for leprosy, where 95.9% of the global total of people detected with leprosy are found. The 23 countries are: Angola, Bangladesh, Brazil, Comoros, Cote Ivoire, DR Congo, Egypt, Ethiopia, India, Indonesia, Kiribati, Madagascar, Micronesia, Mozambique, Myanmar, Nepal, Nigeria, Philippines, South Sudan, Sri Lanka, Sudan, Somalia and Tanzania.
The highest number of people newly detected with leprosy in 2020 live in India with 65,147, followed by Brazil with 17,979 and Indonesia with 11,173.
*WHO Weekly epidemiological record, Global Leprosy Update 10 September 2020, 36, 2021, 96, 421-444